CLDN6 and bladder transitional cell carcinoma: These PMGs, namely CLDN6, CES1, SOST, SPRR2A, CRTAC1, DSG3, MYBPH, CGB5, and KRT1, held considerable promise in predicting the prognosis of BLCA patients.